Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exalgo in Neuropathic Pain
NCT01207596Phase 4Completed
- Sponsor
- International Clinical Research Institute
- Start
- Sep 2010
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hydromorphone in neuropathic pain, sponsored by International Clinical Research Institute. Primary endpoint: Change From Baseline in the Average Pain Over the Last 24 Hrs on the Brief Pain Inventory (BPI) Scale at 12 weeks. Started Sep 2010; status: completed.
02
Drugs
hydromorphone
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01207596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207596.